![]() ![]() It thus became the first prominent Chinese company to halt its US IPO plans after Beijing cracked down on domestic companies listing overseas. Their first quarter revenue for this year was RMB 223 million yuan, up by RMB 159 million yuan from the same period of 2020.īut in July, LinkDoc scrapped plans to list due to market volatility. SEE ALSO: LinkDoc to List on NASDAQ, Sets Sights on $1.5 Billion Market ValueĪccording to the prospectus disclosed by the company itself, the company’s revenue in 20 were RMB 374 million yuan and RMB 942 million yuan respectively, with a year-on-year increase of 89%. ![]() At that time, it was set to raise as much as $211 million from issuing $10.8 million shares at a price of $17.50 to $19.50. In June this year, LinkDoc officially submitted its prospectus to the US Securities and Exchange Commission (SEC) and planned to list on the Nasdaq. The service will work by connecting APPs such as the Ali Health platform with the LinkDoc Internet Hospital and Cancer Patient Service Center. The case examines how LinkDoc, specializing in big data and serving the vertical healthcare industry, found its own answers to these issues and, more specifically, how it identified and entered its target market segment, and. The two sides announced that they will build a patient-centered and innovation-driven service platform, which provides whole-cycle support for cancer patients. The LinkDoc Technology (hereinafter 'LinkDoc') case was compiled as one way to find answers to these questions. In March this year, Alibaba Health made a strategic investment in the company. Since 2015, the company has completed five rounds of financing with investors such as Alibaba Health, Youshan Capital, CBC Capital, Ally Bridge Group and others. IPO, nine months after its 11th hour halt to the listing Three other Chinese companies with pending U.S. They added that the specific plan and details of the Pre-IPO and the Hong Kong IPO could still change.įounded in 2014, LinkDoc specializes in providing big data and artificial intelligence solutions for all parties in the pharmaceutical and medical industries. LinkDoc has formally withdrawn its plan to raise 200 million from a U.S. Beijing, Beijing, China 51-100 Series D Private 21,134 Highlights Total Funding Amount CN1. According to Bloomberg, LinkDoc Technology Limited, a medical data platform company backed by Alibaba Group, plans to lead a $200 to $300 million financing round before its upcoming IPO in Hong Kong.Ī person familiar with the matter said such a plan is still under discussion and no decision has been made yet. LinkDoc Technology Limited is a leading oncology big data company, based in Beijing, China. ![]()
0 Comments
Leave a Reply. |